Oriol Egea-Iborra
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Bone marrow adipocytes fuel emergency hematopoiesis after myocardial infarction.
Journal: Nature cardiovascular research
Published: February 12, 2024
Recruited macrophages elicit atrial fibrillation.
Journal: Science (New York, N.Y.)
Published: July 13, 2023
Preclinical scenario of targeting myocardial fibrosis with chimeric antigen receptor (CAR) immunotherapy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 10, 2022
Bone marrow endothelial dysfunction promotes myeloid cell expansion in cardiovascular disease.
Journal: Nature cardiovascular research
Published: June 24, 2022
Translational proteomics in cardiogenic shock: from benchmark to bedside.
Journal: Journal of geriatric cardiology : JGC
Published: March 23, 2022
Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction.
Journal: Frontiers in cardiovascular medicine
Published: March 01, 2022
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers.
Journal: Frontiers in cardiovascular medicine
Published: March 01, 2022
Commentary: A Review of Prognosis Model Associated With Cardiogenic Shock After Acute Myocardial Infarction.
Journal: Frontiers in cardiovascular medicine
Published: January 17, 2022
Porcine iPSC Generation: Testing Different Protocols to a Successful Application.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 30, 2021
iPSC Therapy for Myocardial Infarction in Large Animal Models: Land of Hope and Dreams.
Journal: Biomedicines
Published: October 31, 2021
Last Updated: 09/26/2026